Repligen Corp. (RGEN)
167.77
+1.25
(+0.75%)
USD |
NASDAQ |
Nov 13, 16:00
167.77
0.00 (0.00%)
After-Hours: 19:59
Repligen Shareholders Equity (Quarterly) : 2.092B for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 2.092B |
| June 30, 2026 | 2.112B |
| March 31, 2026 | 2.105B |
| December 31, 2025 | 2.106B |
| September 30, 2025 | 2.083B |
| June 30, 2025 | 2.062B |
| March 31, 2025 | 1.985B |
| December 31, 2024 | 1.973B |
| September 30, 2024 | 2.017B |
| June 30, 2024 | 1.984B |
| March 31, 2024 | 1.966B |
| December 31, 2023 | 1.965B |
| September 30, 2023 | 1.974B |
| June 30, 2023 | 1.957B |
| March 31, 2023 | 1.927B |
| December 31, 2022 | 1.911B |
| September 30, 2022 | 1.835B |
| June 30, 2022 | 1.805B |
| March 31, 2022 | 1.766B |
| December 31, 2021 | 1.750B |
| September 30, 2021 | 1.715B |
| June 30, 2021 | 1.603B |
| March 31, 2021 | 1.556B |
| December 31, 2020 | 1.529B |
| September 30, 2020 | 1.125B |
| Date | Value |
|---|---|
| June 30, 2020 | 1.100B |
| March 31, 2020 | 1.070B |
| December 31, 2019 | 1.060B |
| September 30, 2019 | 1.045B |
| June 30, 2019 | 878.97M |
| March 31, 2019 | 625.02M |
| December 31, 2018 | 615.57M |
| September 30, 2018 | 606.49M |
| June 30, 2018 | 598.66M |
| March 31, 2018 | 597.18M |
| December 31, 2017 | 591.55M |
| September 30, 2017 | 576.87M |
| June 30, 2017 | 190.94M |
| March 31, 2017 | 176.79M |
| December 31, 2016 | 168.76M |
| September 30, 2016 | 166.52M |
| June 30, 2016 | 163.72M |
| March 31, 2016 | 128.89M |
| December 31, 2015 | 122.75M |
| September 30, 2015 | 121.45M |
| June 30, 2015 | 118.22M |
| March 31, 2015 | 111.93M |
| December 31, 2014 | 111.73M |
| September 30, 2014 | 114.59M |
| June 30, 2014 | 115.56M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 137.58M |
| Precigen, Inc. | 83.79M |
| Agilent Technologies, Inc. | 7.363B |
| Azenta, Inc. | 1.397B |
| Danaher Corp. | 53.62B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.926B |
| Total Liabilities (Quarterly) | 834.67M |
| Debt to Equity Ratio | 0.3309 |
| Current Ratio | 9.882 |
| Net Debt Paydown Yield | -0.01% |